Eledon Pharmaceuticals, Inc.ELDN
Price (close)
$2.68
Market cap
$216.8M
P/E
—
Revenue (TTM)
—
Net income
-$98.6M
Dividend yield
—
1-year total return
8.5%
Net margin
—
Revenue growth
—
Debt / equity
—
What Eledon Pharmaceuticals, Inc. does.
No business description on file yet.
Revenue and profit, by fiscal year.
| Fiscal year | 2020 | 2021 | 2022 | 2023 | 2024 | 2025 |
|---|---|---|---|---|---|---|
| Revenue | — | — | — | — | — | — |
| Net income | -$22.8M | -$34.5M | -$88.0M | -$116.5M | -$36.2M | -$45.6M |
| Free cash flow | — | — | — | — | — | — |
More on ELDN.
- Eledon Pharmaceuticals, Inc. summary
- Eledon Pharmaceuticals, Inc. financial statements
- Eledon Pharmaceuticals, Inc. key metrics
- Eledon Pharmaceuticals, Inc. health scores and style box
- Eledon Pharmaceuticals, Inc. earnings
- Eledon Pharmaceuticals, Inc. dividends
- Eledon Pharmaceuticals, Inc. valuation
- Eledon Pharmaceuticals, Inc. ownership and insiders
- Eledon Pharmaceuticals, Inc. peers
Figures from Eledon Pharmaceuticals, Inc.'s filings with the U.S. SEC, standardised automatically; prices are end-of-day closes. Not financial advice.